About 800 reports

Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026 ##.

  • Cell Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • United States
  • World

Global Dendritic Cell Cancer Vaccine Market Dosage Price & Clinical Trials Outlook 2024 ##.

  • Cell Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • Therapy
  • World
  • THREAT OF NEW ENTRANTS
  • THREAT OF RIVALRY

The number of clinical trials in 2017 increased by approximately ##% from 2015.

  • Regenerative Medicine
  • Medtronic, Inc.
  • MiMedx Group, Inc.
  • Organogenesis, Inc.
  • Zimmer Biomet Holdings, Inc.

Global Dendritic Cell Cancer Vaccine Market & Clinical Trials Outlook 2023 ##.

  • Cancer Immunotherapy
  • Cell Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • World
  • Conferences for the Regenerative Medicine

Additionally it was reported that most of the heart ECM-derived hydrogel form the market player, Vetrigel, Ventrix, Inc. has been used for post infarction treatment in clinical trial (Phase ##).

  • Regenerative Medicine
  • Forecast
  • Market Size
  • Admedus Ltd
  • Biologics, Inc.
  • A : Top 10 countries with enormous stem cell research
  • C: Funding received by California Institute of regenerative medicine

Regenerative drugs present in the clinical trial phase are: Sutimlimab, BIVV##, ST## and BIVV##.

  • Regenerative Medicine
  • World
  • Market Size
  • Amgen Inc.
  • Celgene Corporation

Clinical trials for oncology accounts for a share of ##. ##% of all indications for which clinical trials are being conducted.

  • Regenerative Medicine
  • North America
  • United States
  • World
  • Horizon Discovery
  • GLOBAL GENE THERAPY CLINICAL TRIALS BY THERAPY AREAS; 2017
  • NUMBER OF APPROVED GENE THERAPY TRIALS WORLDWIDE; 1989-2015

ProSavin has already been tested for phase ## and phase ## clinical trials further clinical trials are currently in progress.

  • Regenerative Medicine
  • Boehringer Ingelheim GmbH
  • Celgene Corporation
  • Genzyme Corporation
  • Intrexon Corporation

Global & US Gene Therapy Market Forecast to 2020 ##.

  • Medical Biotechnology
  • Regenerative Medicine
  • United States
  • World
  • Market Size
  • Cell and Gene Therapy Market in Spain 2018-2024 ($ million)
  • The cell and gene therapy market in France was valued at $70 million in 2018 and is

BELLICUM EXPECTS TO SUBMIT AN IND FOR BPX-## AND TO INITIATE A CLINICAL TRIAL IN 2019.

  • Regenerative Medicine
  • World
  • Market Size
  • Gilead Sciences, Inc.
  • Novartis AG
  • STEM CELL CLINICAL TRIALS
  • APPLICATIONS: CLINICAL TRIALS

Currently, more than ## stem cell clinical trials have been registered in China.

  • Cell Therapy
  • Regenerative Medicine
  • United States
  • World
  • Market Size

The study analyzes clinical trials and patents in different regions.

  • Medical Biotechnology
  • Regenerative Medicine
  • Tissue Engineering
  • World
  • Forecast
  • 4.2 Key Trends & Development
  • Hemophilia Gene Therapy Candidates (2017/2018)

An initial spate of clinical trials have began for the treatment of hemophilia with gene transfer.

  • Regenerative Medicine
  • United States
  • World
  • Bayer AG
  • CSL Limited

The market’s projected growth stems from factors such as the rising prevalence of various diseases such as cancer, infectious diseases, and other genetic disorders, the growing trend toward gene therapy owing to their promising clinical results, and increasing partnerships and collaboration

  • Gene Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • World

The growing government funding for regenerative medicines in research institutes along with the growing number of clinical trials based on cell-based therapy and investment in R& D activities is expected to supplement the growth of the stem cell and regenerative market in Asia-P

  • Biopharmaceutical
  • Medical Biotechnology
  • Regenerative Medicine
  • World
  • Market Size

For instance, Royal Free Hospital (U. K. ) and Oxford University Hospital (U. K. ), in 2017, were involved in a Phase I clinical trial of adeno-associated viral vector (FLT##a) in patients with hemophilia B.

  • Gene Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • World
  • Market Size

GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET PROSPECTS 2018-2028 ##.

  • Medical Biotechnology
  • Regenerative Medicine
  • World
  • Market Shares
  • Market Size
  • 11.2.5. KEY CLINICAL TRIAL RESULTS
  • REPRESENTS THE INFORMATION ON THE CLINICAL TRIALS OF STRIMVELIS.

Key Clinical Trial Results ##.

  • Cell Therapy
  • Medical Biotechnology
  • Pathology
  • Regenerative Medicine
  • United States

##. ## Phases of Clinical Trials ##. ## Scope of this Report ##.

  • Cell Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • World
  • PRESENTS THE DISTRIBUTION OF CLINICAL TRIALS OF ENCAPSULATED CELL THERAPIES, ON THE BASIS OF THEIR PHASE.
  • presents a timeline presentation of the number of clinical trials of encapsulated cell-

CLINICAL TRIAL ANALYSIS CLINICAL TRIAL ANALYSIS ##. ##.

  • Eye Disease
  • Regenerative Medicine
  • United States
  • Erytech Pharma SA
  • Neurotech Pharmaceuticals, Inc.

REST OF WORLD PART D: ANNEXURE ##.

  • Regenerative Medicine
  • APAC
  • United States
  • World
  • Market Shares

MOUNTING NUMBER OF VIRAL VECTORS GENE-THERAPY-BASED CLINICAL TRIALS ##. ##. ##.

  • Gene Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • World
  • Market Size

(APPROXIMATELY ##% OF POTENTIAL MEDICINES FAIL DURING CLINICAL TRIALS DUE TO AN INCOMPLETE UNDERSTANDING OF THE BIOLOGICAL TARGET OF A DRUG FOR THAT DISEASE.

  • Cell Therapy
  • Hospital
  • Regenerative Medicine
  • Research And Development
  • Tissue Banking
  • EXOSOME TECHNOLOGIES, GLOBAL, TYPES OF VIRAL VECTOR FOR GENE THERAPY DELIVERY, 2018
  • EXOSOME TECHNOLOGIES, GLOBAL, RENEURON COMPLETED DEALS, 2018

Results from Preclinical studies are yet to be reported; however, one Phase I clinical trial is planned for the therapy.

  • Regenerative Medicine
  • CAP-1002 group
  • Capricor Therapeutics, Inc.
  • Mirna Therapeutics, Inc.
  • ReNeuron Group plc
  • CLINICAL TRIALS
  • CRITICAL ETHICAL CHALLENGES IN CLINICAL TRIAL DESIGN

If vendors fail to provide clinical data with positive results in one specific region, then it can lead to cost burden and can cause uncertainty or impact the other trials.

  • Regenerative Medicine
  • Biogen Idec Inc.
  • Novo Nordisk Group
  • Seattle Genetics, Inc.
  • Takeda Pharmaceutical Company Limited

The cell and gene therapy growth has been primarily attributed to the major drivers in this market such as increasing prevalence of cancer and chronic diseases, rising number of clinical trials for cell and gene therapy, steady investment and consolidation in the cell and gene ther

  • Gene Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • World
  • Market Size
  • HEADING:
  • MARKET CHALLENGES

One of the major causes for the exorbitant cost of gene therapy is the requirement of intensive clinical trials.

  • Regenerative Medicine
  • Therapy
  • Forecast
  • Market Size
  • Celgene Corporation
  • Clinical study
  • Regulation of CAR Cell Therapies in Japan

From clinical trials, you can see that the vast majority at one month did respond.

  • Regenerative Medicine
  • United States
  • Celgene Corporation
  • Gilead Sciences, Inc.
  • Novartis AG

& nbsp; • What types of clinical trials are currently being performed by stakeholders and major players?

  • Cell Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • World
  • Forecast

RISING NUMBER OF CLINICAL TRIALS ASSOCIATED WITH STEM CELL RESEARCH ##. ##.

  • Cell Therapy
  • Medical Biotechnology
  • Regenerative Medicine
  • World